Is Cardio Diagnostics Holdings, Inc. (CDIO) a Buy, Sell, or Hold?
Cardio Diagnostics Holdings, Inc.
NASDAQ:CDIO
$1.8 USD
$0.01 (0.56%)
- Volume
- 17.75K
- Average Volume
- 59.36K
- Market Capitalization
- $3.73M
- P/E Ratio
- -0.53
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $7.91
- Year Low
- $0.97
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $15.76
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
16
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
0
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ -
CDIO Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CDIO Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Fung Peter K | director | 2026-06-30 | A-Award | 2.19 | 2026-07-02 |
| Betts Wendy J | director | 2026-06-30 | A-Award | 2.19 | 2026-07-02 |
| Intrater James | director | 2026-06-30 | A-Award | 2.19 | 2026-07-02 |
| Burton Paul Frederick | director | 2026-06-30 | A-Award | 2.19 | 2026-07-02 |
| Fung Peter K | director | 2026-03-31 | A-Award | 1.95 | 2026-04-02 |
| Betts Wendy J | director | 2026-03-31 | A-Award | 1.95 | 2026-04-02 |
| Intrater James | director | 2026-03-31 | A-Award | 1.95 | 2026-04-02 |
| Burton Paul Frederick | director | 2026-03-31 | A-Award | 1.95 | 2026-04-02 |
| Fung Peter K | director | 2025-12-31 | A-Award | 2.71 | 2026-01-06 |
| Betts Wendy J | director | 2025-12-31 | A-Award | 2.71 | 2026-01-06 |
| Intrater James | director | 2025-12-31 | A-Award | 2.71 | 2026-01-06 |
| Burton Paul Frederick | director | 2025-12-31 | A-Award | 2.71 | 2026-01-06 |
| Fung Peter K | director | 2025-09-30 | A-Award | 4.01 | 2025-10-03 |
| Betts Wendy J | director | 2025-09-30 | A-Award | 4.01 | 2025-10-03 |
| Intrater James | director | 2025-09-30 | A-Award | 4.01 | 2025-10-03 |
| Burton Paul Frederick | director | 2025-09-30 | A-Award | 4.01 | 2025-10-03 |
| Fung Peter K | director | 2025-06-30 | A-Award | 3.6 | 2025-07-02 |
| Betts Wendy J | director | 2025-06-30 | A-Award | 3.6 | 2025-07-02 |
| Intrater James | director | 2025-06-30 | A-Award | 3.6 | 2025-07-02 |
| Burton Paul Frederick | director | 2025-06-30 | A-Award | 3.6 | 2025-07-02 |
| Fung Peter K | director | 2025-03-31 | A-Award | 0.33 | 2025-04-01 |
| Betts Wendy J | director | 2025-03-31 | A-Award | 0.33 | 2025-04-01 |
| Burton Paul Frederick | director | 2025-03-31 | A-Award | 0.33 | 2025-04-01 |
| Intrater James | director | 2025-03-31 | A-Award | 0.33 | 2025-04-01 |
| Fung Peter K | director | 2024-12-31 | 0.92 | 2025-03-13 | |
| Betts Wendy J | director | 2024-12-31 | 0.92 | 2025-02-05 | |
| Burton Paul Frederick | director | 2024-12-31 | A-Award | 0.92 | 2025-01-15 |
| Intrater James | director | 2024-12-31 | A-Award | 0.92 | 2025-01-15 |
| Levy Oded | director | 2024-09-30 | A-Award | 0.22 | 2024-10-10 |
| Lau Stanley K. | director | 2024-09-30 | A-Award | 0.22 | 2024-10-10 |
| Intrater James | director | 2024-09-30 | A-Award | 0.22 | 2024-10-10 |
| Burton Paul Frederick | director | 2024-09-30 | A-Award | 0.22 | 2024-10-10 |
| Dogan Timur | officer: Chief Technology Officer | 2024-09-06 | P-Purchase | 0.29 | 2024-10-09 |
| Dogan Meeshanthini | director, officer: Chief Executive Officer | 2024-09-06 | P-Purchase | 0.29 | 2024-10-08 |
| Philibert Robert | director, officer: Chief Medical Officer | 2024-09-06 | P-Purchase | 0.2848 | 2024-09-10 |
| Philibert Robert | director, officer: Chief Medical Officer | 2024-09-06 | P-Purchase | 0.287 | 2024-09-10 |
| Dogan Meeshanthini | officer: Chief Technology Officer | 2024-09-06 | P-Purchase | 0.29 | 2024-09-09 |
| Dogan Meeshanthini | director, officer: Chief Executive Officer | 2024-09-06 | P-Purchase | 0.29 | 2024-09-09 |
| Levy Oded | director | 2024-06-30 | A-Award | 0.55 | 2024-07-02 |
| Lau Stanley K. | director | 2024-06-30 | A-Award | 0.55 | 2024-07-02 |
| Intrater James | director | 2024-06-30 | A-Award | 0.55 | 2024-07-02 |
| Burton Paul Frederick | director | 2024-06-30 | A-Award | 0.55 | 2024-07-02 |
| Burton Paul Frederick | director | 2024-03-31 | M-Exempt | 1.42 | 2024-04-08 |
| Burton Paul Frederick | director | 2024-03-31 | M-Exempt | 0 | 2024-04-08 |
| Lau Stanley K. | director | 2024-03-31 | M-Exempt | 1.42 | 2024-04-08 |
| Lau Stanley K. | director | 2024-03-31 | M-Exempt | 0 | 2024-04-08 |
| Intrater James | director | 2024-03-31 | M-Exempt | 1.42 | 2024-04-08 |
| Intrater James | director | 2024-03-31 | M-Exempt | 0 | 2024-04-08 |
| Levy Oded | director | 2024-03-31 | M-Exempt | 1.42 | 2024-04-08 |
| Levy Oded | director | 2024-03-31 | M-Exempt | 0 | 2024-04-08 |
| Lau Stanley K. | director | 2024-01-23 | A-Award | 0 | 2024-02-21 |
| Intrater James | director | 2024-01-23 | A-Award | 0 | 2024-02-21 |
| Burton Paul Frederick | director | 2024-01-23 | A-Award | 0 | 2024-02-21 |
| Levy Oded | director | 2024-01-23 | A-Award | 0 | 2024-02-21 |
| Luqman Elisa V | officer: Chief Financial Officer | 2024-01-23 | A-Award | 2.11 | 2024-02-21 |
| Abdullahi Khullani | officer: VP of Revenue and Strategy | 2024-01-23 | A-Award | 2.11 | 2024-02-21 |
| Philibert Robert | director, officer: Chief Medical Officer | 2024-01-23 | A-Award | 2.11 | 2024-02-21 |
| Hosseinion Warren | director | 2024-01-23 | A-Award | 2.11 | 2024-02-21 |
| Dogan Timur | officer: Chief Technology Officer | 2024-01-23 | A-Award | 2.11 | 2024-02-21 |
| Dogan Timur | officer: Chief Technology Officer | 2024-01-23 | A-Award | 2.11 | 2024-02-21 |
| Dogan Meeshanthini | director, officer: Chief Executive Officer | 2024-01-23 | A-Award | 2.11 | 2024-02-21 |
| Dogan Meeshanthini | director, officer: Chief Executive Officer | 2024-01-23 | A-Award | 2.11 | 2024-02-21 |
| Lau Stanley K. | director | 2024-01-31 | M-Exempt | 2.18 | 2024-02-05 |
| Lau Stanley K. | director | 2024-01-31 | M-Exempt | 0 | 2024-02-05 |
| Burton Paul Frederick | director: | 2023-12-18 | 0 | 2024-01-04 | |
| Levy Oded | director | 2023-12-31 | M-Exempt | 2.49 | 2024-01-02 |
| Levy Oded | director | 2023-12-31 | M-Exempt | 0 | 2024-01-02 |
| Sim Brandon | director | 2023-12-31 | M-Exempt | 2.49 | 2024-01-02 |
| Sim Brandon | director | 2023-12-31 | M-Exempt | 0 | 2024-01-02 |
| Intrater James | director | 2023-12-31 | M-Exempt | 2.49 | 2024-01-02 |
| Intrater James | director | 2023-12-31 | M-Exempt | 0 | 2024-01-02 |
| Levy Oded | director | 2023-12-31 | P-Purchase | 0 | 2024-01-02 |
| Lau Stanley K. | director | 2023-12-31 | M-Exempt | 2.49 | 2024-01-02 |
| Lau Stanley K. | director | 2023-12-31 | M-Exempt | 2.49 | 2024-01-02 |
| Lau Stanley K. | director | 2023-12-31 | M-Exempt | 0 | 2024-01-02 |
| Lau Stanley K. | director | 2023-10-31 | M-Exempt | 0.3016 | 2023-11-03 |
| Dogan Timur | officer: Chief Technology Officer | 2023-06-23 | A-Award | 1.26 | 2023-11-03 |
| Dogan Timur | officer: Chief Technology Officer | 2023-06-23 | A-Award | 1.26 | 2023-11-03 |
| Lau Stanley K. | director | 2023-09-30 | M-Exempt | 0.34 | 2023-10-04 |
| Lau Stanley K. | director | 2023-09-30 | M-Exempt | 0.34 | 2023-10-04 |
| Lau Stanley K. | director | 2023-08-31 | M-Exempt | 0.5499 | 2023-10-04 |
| Lau Stanley K. | director | 2023-07-31 | M-Exempt | 1.21 | 2023-10-04 |
| Lau Stanley K. | director | 2023-09-30 | M-Exempt | 0 | 2023-10-04 |
| Levy Oded | director | 2023-09-30 | M-Exempt | 0.34 | 2023-10-04 |
| Levy Oded | director | 2023-09-30 | P-Purchase | 0 | 2023-10-04 |
| Intrater James | director | 2023-09-30 | M-Exempt | 0.34 | 2023-10-04 |
| Intrater James | director | 2023-09-30 | P-Purchase | 0 | 2023-10-04 |
| Sim Brandon | director | 2023-09-30 | M-Exempt | 0.34 | 2023-10-04 |
| Sim Brandon | director | 2023-09-30 | M-Exempt | 0 | 2023-10-04 |
| Levy Oded | director | 2023-09-30 | M-Exempt | 0 | 2023-10-03 |
| Intrater James | director | 2023-09-30 | M-Exempt | 0 | 2023-10-03 |
| Sim Brandon | director | 2023-09-30 | M-Exempt | 0 | 2023-10-03 |
| Dogan Meeshanthini | director, 10 percent owner, officer: Chief Executive Officer | 2023-08-31 | P-Purchase | 0.545 | 2023-09-08 |
| Dogan Meeshanthini | director, 10 percent owner, officer: Chief Executive Officer | 2023-08-25 | P-Purchase | 0.555 | 2023-09-08 |
| Dogan Timur | officer: Chief Technology Officer | 2023-08-31 | P-Purchase | 0.545 | 2023-09-08 |
| Dogan Timur | officer: Chief Technology Officer | 2023-08-25 | P-Purchase | 0.555 | 2023-09-08 |
| Philibert Robert | director, 10 percent owner, officer: Chief Medical Officer | 2023-08-28 | P-Purchase | 0.57 | 2023-09-05 |
| Philibert Robert | director, 10 percent owner, officer: Chief Medical Officer | 2023-08-28 | P-Purchase | 0.5999 | 2023-09-05 |
| Philibert Robert | director, 10 percent owner, officer: Chief Medical Officer | 2023-08-24 | P-Purchase | 0.6 | 2023-09-05 |
| Lau Stanley K. | director | 2023-07-01 | M-Exempt | 1.19 | 2023-07-05 |